Curtis Bloch Email Address

Global Marketing and Strategic Planning and Innovation and Product Ideation and Marketing and Sales Leadership and Commercialization

CU Medical, Inc. (Nasdaq:ICUI) develops, manufactures and sells innovative medical technologies.

PROFESSIONAL SUMMARY: Seasoned, multi-national corporate business leader with entrepreneurial/small company spirit and experience. ♦ Market leading medical device, diagnostic and pharmaceutical experience ♦ 95% success rate in exceeding revenue and gross profit objectives ♦ Managed annual revenues ranging from $5 million to $300 million ♦ Experienced in leading high profile SBU and corporate initiatives Proven success in creating long-term profitable growth through effective strategic marketing, new product development, pricing management, and commercial execution. ♦ New Product Development (3) - 5 year revenue of $161.9 million ♦ Adjacent Market Strategies (4) - 5 year revenue of $89.4 million ♦ Strategic Pricing Programs (2) - 5 year revenue of $15.5 million Developed, led, or implemented six major market development campaigns in the pharmaceutical, medical device and diagnostic industries. ♦ Industry leading direct-to-consumer (DTC) campaign - pharmaceuticals ♦ Emerging diagnostic criteria and therapeutic treatment options - pharmaceuticals ♦ Healthcare worker and patient safety legislation – medical device & diagnostics Specialties: Infectious Disease | Molecular Diagnostics | Healthcare Associated Infections | Infection Surveillance & Data Management Software | Patient Safety | Bloodborne Pathogens | Healthcare Worker Safety | Blood Collection | Specimen Collection | Pharmaceuticals | Drug Delivery | Self-Administration | Infusion Therapy | Fluid Management | Peripheral Vascular Access | Venous Access | Arterial Access |